HEOR Sr Director/ Director- Strategy Leader

Role: HEOR Strategy Leader within Lilly's cardiometabolic health (CMH) unit, responsible for shaping and executing health outcomes evidence strategies (health economics, patient-reported outcomes, real-world evidence) to support drug development, market access, and product differentiation. Key responsibilities include developing research strategies across product lifecycle stages, leading high-impact scientific studies, influencing cross-functional teams, and managing a team of HEOR scientists. The role emphasizes integrating HEOR insights into clinical and commercial decisions, conducting research to inform regulatory, pricing, and reimbursement needs, and disseminating results through scientific communication. Requirements: PhD/MD or PharmD/MS with 7+ years of experience in HEOR, with demonstrated leadership and strategic planning skills. Preferred skills include strong communication, influence within teams, experience leading HEOR strategies across portfolios or therapeutic areas, and people management expertise. High-value specifics: focus on cardiometabolic conditions, evidence generation for product value propositions, and global market considerations, with 10-25% travel; location options include Indianapolis or remote in the US.